Cisplatin-DNA damage recognition proteins in human tumour extracts.

about

Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.A human factor that recognizes DNA substituted with 2-chloroadenine, an antileukemic purine analog.

P2860

Q33944454-014AAFE2-0CDF-48D5-B890-6F821634866B Q38292889-14C7E5EF-62C4-4826-8C22-A0B482A6DEB6

P2860

Cisplatin-DNA damage recognition proteins in human tumour extracts.

Item

http://www.wikidata.org/entity/Q35976534

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@ast

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@en

type

Item

label

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@ast

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@en

prefLabel

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@ast

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@en

P1476

Cisplatin-DNA damage recognition proteins in human tumour extracts.

@en

P2093

Bissett D

http://www.w3.org/2001/XMLSchema#string

Brown R

http://www.w3.org/2001/XMLSchema#string

Kelland LR

http://www.w3.org/2001/XMLSchema#string

McLaughlin K

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin

A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system

Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA

Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA.

The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove.

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA.

P2888

bjc.1993.135

P304

742-748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1993.135

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1993-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14728744

http://www.w3.org/2001/XMLSchema#string

P698

8471431

http://www.w3.org/2001/XMLSchema#string

P921

DNA damage

P932

1968372

http://www.w3.org/2001/XMLSchema#string

Cisplatin-DNA damage recognition proteins in human tumour extracts.

about

P2860

P2860

Cisplatin-DNA damage recognition proteins in human tumour extracts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932